New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 10, 2014
07:21 EDTSEMSelect Medical management to meet with UBS
Meeting to be held in Princeton, NJ on April 10 hosted by UBS.
News For SEM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 24, 2015
08:49 EDTSEMHumana price target raised to $193 from $167 at Oppenheimer
Oppenheimer increased its price target on Humana (HUM) to reflect the company's sale of Concentra to Select Medical (SEM) and Welsh Carson for $1.055B. The firm says that the deal is likely to be supportive of Humana's earnings growth over the longer term. It keeps an Outperform rating on the shares.
March 23, 2015
12:17 EDTSEMOn The Fly: Midday Wrap
Subscribe for More Information
09:07 EDTSEMSelect Medical agrees to acquire Concentra through JV with Welsh Carson
Subscribe for More Information
09:04 EDTSEMHumana to sell Concentra to Select Medical, Welsh Carson for $1.055B in cash
Humana (HUM) has reached a definitive agreement to sell the stock of its wholly-owned subsidiary, Concentra, to MJ Acquisition Corporation, a joint venture between Select Medical Holdings Corporation (SEM), an operator of specialty hospitals and outpatient rehabilitation clinics in the U.S., and Welsh, Carson, Anderson & Stowe XII, L.P., a private equity fund, for approximately $1.055B in cash, subject to customary adjustments. Humana acquired Concentra in December 2010. Subsequently, the assets of certain privately-operated Community Based Outpatient Clinics were transferred into Concentra. Additionally, Humana has divested certain Concentra non-core assets over the past four years. The decision to divest Concentra demonstrates the company’s commitment to its previously announced business portfolio review. Humana will continue performing its review of the alignment and return potential of businesses across the organization to ensure each supports the company’s integrated care delivery strategy and earns the appropriate return on invested capital. The Concentra transaction is anticipated to close during the second quarter of 2015 subject to Hart Scott Rodino regulatory clearance and customary closing conditions. Humana anticipates using the net proceeds from the transaction to advance its strategic growth priorities, to fund additional share repurchases under its existing $2 billion authorization and for general corporate purposes. Goldman, Sachs & Co. is acting as financial advisor to Humana. Fried, Frank, Harris, Shriver & Jacobson LLP is acting as legal advisor to Humana. Concentra reported revenues for the year ended December 31, 2014 were approximately $1B. Humana anticipates the Concentra divestiture will be slightly dilutive to 2015 EPS excluding any one-time gain expected upon the close of the transaction.
09:02 EDTSEMHumana to sell Concentra to Select Medical, Welsh Carson for $1.055B in cash
08:07 EDTSEMBofA/Merrill healthcare high yield analyst has analyst/industry conference call
Healthcare High Yield Analyst Bland provides an update on the current state of the bond markets and the ability of healthcare providers to utilize debt financing on an Analyst/Industry conference call to be held on March 24 at 10 am.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use